Screener
Arcutis Biotherapeutics, Inc. ARQT Q1 2025 earnings
Reported May 6, 2025 · After market close
Revenue$65.8MMiss by $6.9M
EPS-$0.20Beat by $0.01
Revenue estimate$72.7M
EPS estimate-$0.21
Next report
Oct 27, 2026 (in a month)Revenue estimate$141.7M
EPS estimate$0.17
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Arcutis Biotherapeutics, Inc. report Q1 2025 earnings?
- Arcutis Biotherapeutics, Inc. (ARQT) reported Q1 2025 earnings on May 6, 2025 after market close.
- What were Arcutis Biotherapeutics, Inc.'s Q1 2025 revenue and EPS?
- Arcutis Biotherapeutics, Inc. reported revenue of $65.8M and eps of $-0.20 for Q1 2025.
- Did Arcutis Biotherapeutics, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $72.7M by $6.9M. EPS beat the consensus estimate of $-0.21 by $0.01.
- How did Arcutis Biotherapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 32.8% from $49.6M a year earlier and eps grew 37.5% from $-0.32.
- Where can I find Arcutis Biotherapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001787306-25-000091) and the 10-Q periodic report (0001787306-25-000092) directly on SEC EDGAR. The filing index links above go to sec.gov.
